Compare OHI & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OHI | ICLR |
|---|---|---|
| Founded | N/A | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1B | 14.3B |
| IPO Year | N/A | 1998 |
| Metric | OHI | ICLR |
|---|---|---|
| Price | $44.01 | $173.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 14 |
| Target Price | $45.67 | ★ $202.38 |
| AVG Volume (30 Days) | ★ 2.0M | 1.0M |
| Earning Date | 02-04-2026 | 10-22-2025 |
| Dividend Yield | ★ 6.09% | N/A |
| EPS Growth | ★ 31.87 | N/A |
| EPS | 1.80 | ★ 7.47 |
| Revenue | $1,150,200,000.00 | ★ $8,102,602,000.00 |
| Revenue This Year | $12.80 | N/A |
| Revenue Next Year | $8.35 | $0.76 |
| P/E Ratio | $24.44 | ★ $23.25 |
| Revenue Growth | ★ 13.72 | N/A |
| 52 Week Low | $35.04 | $125.10 |
| 52 Week High | $46.36 | $228.29 |
| Indicator | OHI | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 46.22 | 44.29 |
| Support Level | $44.03 | $178.80 |
| Resistance Level | $44.95 | $185.31 |
| Average True Range (ATR) | 0.75 | 6.88 |
| MACD | -0.26 | -1.11 |
| Stochastic Oscillator | 19.66 | 3.67 |
Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.